CC2D1B Antibody
Description
Target Protein
CC2D1B antibodies are immunoglobulins specifically designed to recognize and bind to the Coiled-coil and C2 domain containing 1B (CC2D1B) protein. Also known as Freud-2 or lethal (2) giant discs-1, CC2D1B belongs to the evolutionary conserved Lgd protein family present in all multicellular animals . The protein contains four tandem repeats of the DM14 domain, which facilitate interaction with endosomal sorting complex ESCRT-III, and one C2 domain that enables binding to membrane lipids . These structural features are critical for its cellular functions and similar to those found in its homolog CC2D1A, though the proteins have distinct roles in cellular processes .
Expression and Function of Target Protein
CC2D1B is expressed in multiple tissues with enrichment in the central and peripheral nervous systems, particularly in myelinating cells including oligodendrocytes and Schwann cells . Functionally, CC2D1B acts as a repressor of serotonin 1A receptor expression, contributes to endosomal trafficking, and plays a crucial role in developmental myelination . Studies using knockout mouse models have demonstrated that CC2D1B is especially important for the proper myelination of large diameter fibers in optic nerves, highlighting its significance in central nervous system development .
Molecular Structure
Like all antibodies, CC2D1B antibodies possess the characteristic Y-shaped structure consisting of four polypeptide chains: two identical heavy chains and two identical light chains . This configuration creates two antigen-binding sites at the variable fragment (Fab) region, which specifically recognize epitopes on the CC2D1B protein . The crystallizable fragment (Fc) region contains constant heavy chain domains with conserved glycosylation sites that influence the interaction with effector molecules .
Physical and Chemical Properties
Most commercially available CC2D1B antibodies are rabbit-derived polyclonal IgG immunoglobulins provided in unconjugated liquid form . The observed molecular weight of the target protein is approximately 120 kDa, which is higher than the calculated 94 kDa, likely due to post-translational modifications . These antibodies demonstrate specificity for human, mouse, and rat samples with high sequence homology, as indicated in Table 1 .
Table 1: Species Reactivity of Common CC2D1B Antibodies
| Species | Reactivity Percentage | Application Validation |
|---|---|---|
| Human | 100% | WB, ELISA, IP |
| Mouse | 100% | WB, ELISA |
| Rat | 100% | WB |
| Rabbit | 100% | Predicted |
| Pig | 100% | Predicted |
| Horse | 92% | Predicted |
| Dog | 92% | Predicted |
| Bovine | 92% | Predicted |
| Guinea pig | 92% | Predicted |
Polyclonal Antibody Production
The majority of commercially available CC2D1B antibodies are polyclonal antibodies produced through animal immunization protocols . This process typically begins with the immunization of rabbits using either recombinant CC2D1B protein or synthetic peptides corresponding to specific regions of the protein . Following multiple immunizations over several weeks, serum is collected and antibodies are isolated through affinity purification techniques . This approach yields heterogeneous mixtures of antibodies that recognize different epitopes of the CC2D1B protein, providing robust detection capabilities across various applications .
Monoclonal Antibody Production
Monoclonal CC2D1B antibodies can be generated using hybridoma technology, which provides increased specificity compared to polyclonal antibodies . This method involves immunizing animals (typically mice) with CC2D1B antigen, harvesting antibody-producing B cells from the spleen, and fusing these cells with immortal myeloma cells to create hybridomas . These hybrid cells are then screened for antibody production and performance, with selected clones expanded to produce monoclonal antibodies that recognize a single epitope of CC2D1B .
Recombinant Antibody Production
Recombinant production represents the newest approach for generating CC2D1B antibodies, offering advantages in consistency and specificity . This method involves cloning antibody-coding genes into expression vectors, which are then introduced into mammalian cell lines such as HEK293 or CHO-K1 . These expression systems preserve proper post-translational modifications essential for antibody function while enabling more controlled production conditions . Recombinant antibodies can be produced more rapidly than traditional methods, typically requiring half the time of conventional approaches .
Western Blot
CC2D1B antibodies are frequently utilized in Western blot applications to detect the presence of CC2D1B protein in various tissue and cell lysates . For optimal results, these antibodies are typically diluted at 1:1000-1:4000 in 5% skim milk/PBS buffer, with HRP-conjugated secondary antibodies diluted at 1:50000-1:100000 . Western blotting with CC2D1B antibodies has been instrumental in confirming knockout models and examining expression patterns across different tissues and developmental stages .
Immunoprecipitation
Immunoprecipitation using CC2D1B antibodies enables the isolation of CC2D1B protein from complex biological samples for subsequent analysis . This technique has been particularly valuable for investigating protein-protein interactions involving CC2D1B, such as its association with the ESCRT-III component CHMP4B . Recommended antibody concentrations for immunoprecipitation typically range from 0.5-4.0 μg per reaction .
Immunohistochemistry and Immunocytochemistry
These visualization techniques employ CC2D1B antibodies to detect the presence and localization of CC2D1B protein within tissues and cells . Research studies have used these methods to analyze CC2D1B expression in brain sections, revealing its distribution in oligodendrocytes and other neural cell types . In particular, immunohistological studies have been crucial for examining the impact of CC2D1B knockout on myelination in various brain regions .
ELISA
Enzyme-linked immunosorbent assays utilizing CC2D1B antibodies enable the detection and quantification of CC2D1B protein in heterogeneous samples . Commercial CC2D1B antibodies typically demonstrate ELISA titers of approximately 1:62500 when used with peptide-based assays . This application provides a sensitive method for measuring CC2D1B levels across different experimental conditions .
Role in Developmental Myelination
Research utilizing CC2D1B antibodies has revealed critical insights into the protein's function during developmental myelination. Studies employing these antibodies demonstrated that CC2D1B is highly expressed in myelinating and non-myelinating Schwann cells in mouse sciatic nerves . A seminal study by Manzini et al. showed that CC2D1B knockout mice exhibit hypomyelination of large diameter fibers (>1.5 μm) in optic nerves, with a significant difference in g-ratio measurements between knockout (0.844 ± 0.022) and control animals (0.832 ± 0.016; P-value ≤ 0.05) . These findings established CC2D1B as an important regulator of central nervous system myelination.
Endosomal Trafficking Function
CC2D1B antibodies have been instrumental in elucidating the protein's role in endosomal trafficking. Immunofluorescence studies revealed that CC2D1B cycles between the cytosol and endosomal membranes, with accumulation on endosomes when VPS4 function is reduced . Research showed that the average size of endosomes increases in CC2D1A mutant cells but not in CC2D1B mutant cells, indicating specific roles in endosomal morphogenesis . These discoveries highlight the importance of CC2D1B in maintaining proper endosomal function.
Transcriptional Regulation
CC2D1B antibodies have helped establish the protein's function as a transcriptional regulator. Studies demonstrated that CC2D1B can bind to a dual repressor element in the HTR1A promoter and repress the expression of serotonin 1A receptor in neurons . This finding suggests that CC2D1B could influence serotonin signaling in oligodendrocytes, potentially explaining its impact on myelination in large diameter fibers .
Neurodevelopmental Implications
Research with CC2D1B antibodies has provided insights into the protein's significance in neurodevelopment and cognitive function. Studies revealed that while CC2D1B knockout mice are viable and fertile, they exhibit specific cognitive deficits, including delayed memory acquisition and retention . Interestingly, the related protein CC2D1A is implicated in intellectual disability and autism spectrum disorder, suggesting both proteins contribute to proper brain development through partially overlapping functions .
Antibody Validation Methods
Proper validation of CC2D1B antibodies is essential for ensuring reliable research outcomes. Common validation strategies include testing with knockout models, peptide competition assays, and cross-reactivity assessments. As documented in multiple studies, CC2D1B antibodies have been validated using CC2D1B knockout mice, confirming their specificity for the target protein . Additionally, validation through ELISA using bacterially-expressed human and mouse GST-CC2D1B has established sensitivity and specificity parameters for these reagents .
Application-Specific Parameters
The performance of CC2D1B antibodies varies across different applications, with specific technical parameters optimized for each method. Table 2 summarizes recommended dilutions and conditions for various applications.
Table 2: Application-Specific Parameters for CC2D1B Antibodies
| Application | Recommended Dilution | Incubation Conditions | Detection Method |
|---|---|---|---|
| Western Blot | 1:1000-1:4000 | Overnight at 4°C | HRP-conjugated secondary antibody (1:50000-1:100000) |
| Immunoprecipitation | 0.5-4.0 μg per reaction | 2-4 hours at 4°C | Protein A/G beads |
| ELISA | 1:62500 | 1-2 hours at room temperature | HRP-conjugated detection system |
| Immunohistochemistry | 1:100-1:500 | Overnight at 4°C | Fluorophore-conjugated secondary antibody |
Cross-Reactivity and Specificity
An important consideration when working with CC2D1B antibodies is their potential cross-reactivity with related proteins, particularly CC2D1A. Studies have confirmed that properly validated CC2D1B antibodies show minimal cross-reactivity with CC2D1A, despite the structural similarities between these proteins . This specificity is critical for accurately interpreting research findings, especially in studies examining the distinct functions of these related proteins.
Research-Only Restriction
Current commercial CC2D1B antibodies are explicitly labeled "For Research Use Only" and are not approved for diagnostic procedures . Despite the potential relevance of CC2D1B in neurodevelopmental disorders, no clinical or diagnostic applications have been established for these antibodies, representing a significant limitation in their utilization .
Technical Challenges
Several technical challenges remain in working with CC2D1B antibodies. Some studies have reported difficulties in obtaining specific histological staining with certain CC2D1B antibodies . Additionally, the observed molecular weight of CC2D1B (120 kDa) differs significantly from the calculated weight (94 kDa), which can complicate protein identification and analysis .
Future Research Opportunities
The growing understanding of CC2D1B's role in neurodevelopment suggests several promising directions for future research using CC2D1B antibodies. Potential areas include investigating CC2D1B's contribution to neurodevelopmental disorders, exploring its interactions with signaling pathways such as MAPK, AKT, and NF-κB, and examining its function in specific neuronal populations . Development of more specific monoclonal and recombinant antibodies could enhance the precision of these investigations and potentially lead to diagnostic applications in the future.
Product Specs
Target Background
- CC2D1B regulates the degradation and signaling of EGFR and TLR4. PMID: 27769858
- Human Freud-2/CC2D1B binds to the 5-HT1A dual repressor element and represses the human 5-HT1A receptor gene, thereby regulating its expression in non-serotonergic cells and neurons. PMID: 19423080
- This paper describes a function of Cc2d1b/Cc2d1a and their Drosophila homologue l(2)gd in D.melanogaster in Notch trafficking. PMID: 17084358
Q&A
What is CC2D1B and what cellular functions does it perform?
CC2D1B (Coiled-coil and C2 domain containing 1B) belongs to the evolutionary conserved Lgd protein family with members in all multi-cellular animals. It consists of 858 amino acids with a calculated molecular weight of 94 kDa, though it's typically observed at approximately 120 kDa in Western blots due to post-translational modifications .
CC2D1B functions include:
-
Endosomal trafficking (similar to its Drosophila ortholog Lgd)
-
Transcriptional repression, particularly of the serotonin receptor gene 5-HT1A
-
Regulation of developmental myelination in the central nervous system
-
Involvement in the mitotic reformation of the nuclear envelope
While CC2D1B shares structural features with its homolog CC2D1A, their functions are not fully redundant as evidenced by their distinct knockout phenotypes and expression patterns .
What are the recommended applications for CC2D1B antibody?
Based on validated research applications, CC2D1B antibody has been successfully employed in multiple experimental techniques:
| Application | Recommended Dilution | Validated Samples |
|---|---|---|
| Western Blot (WB) | 1:1000-1:4000 | Mouse brain, human placenta, mouse kidney, SH-SY5Y cells |
| Immunoprecipitation (IP) | 0.5-4.0 μg for 1.0-3.0 mg protein | Mouse brain tissue |
| Immunofluorescence (IF) | Sample-dependent | Various neural tissues |
| Enzyme-linked immunosorbent assay (ELISA) | Application-specific | Multiple species |
The antibody shows confirmed reactivity with human, mouse, and rat samples . When using CC2D1B antibody, researchers should note that the observed molecular weight (~120 kDa) differs from the calculated value (94 kDa) due to post-translational modifications .
How is CC2D1B antibody validated for research use?
Multiple complementary approaches ensure CC2D1B antibody validity:
-
Knockout model validation: The most definitive validation involves testing against tissues from Cc2d1b knockout mice, which should show no signal compared to wild-type controls .
-
Knockdown validation: siRNA or shRNA silencing of Cc2d1b provides an alternative validation approach, with antibody signal reduction corresponding to knockdown efficiency .
-
Cross-reactivity testing: Validated CC2D1B antibodies show specificity with no cross-reactivity to the homologous protein CC2D1A, as demonstrated by unchanged CC2D1A levels after Cc2d1b silencing .
-
Pre-absorption controls: For immunohistochemistry applications, pre-incubating the antibody with purified CC2D1B protein before staining should eliminate specific signal .
-
Molecular weight verification: Though calculated at 94 kDa, reliable CC2D1B antibodies detect a band at approximately 120 kDa due to post-translational modifications .
How does CC2D1B contribute to myelination in the central nervous system?
CC2D1B plays a specific role in developmental myelination, particularly in the central nervous system. Research using Cc2d1b knockout mice has revealed several key insights:
-
Regional specificity: While peripheral nervous system myelination appeared normal in Cc2d1b knockout animals, the central nervous system (specifically optic nerves) showed hypomyelination compared to control animals (g-ratio of 0.844 ± 0.022 in knockout vs. 0.832 ± 0.016 in controls) .
-
Fiber-type specificity: The hypomyelination phenotype was most pronounced in large diameter myelinated fibers .
-
Temporal expression pattern: Cc2d1b is highly expressed between postnatal days 5 (P5) and P20 in vivo, which coincides with active myelination periods .
-
In vitro myelination defects: Silencing of Cc2d1b in Schwann cells significantly decreased the number of myelin segments formed in co-culture with dorsal root ganglia neurons .
-
Distinct from CC2D1A function: The myelination phenotype appears specific to CC2D1B, as its homolog CC2D1A has different expression patterns and knockout phenotypes .
This evidence collectively suggests CC2D1B contributes to transcriptional regulation during oligodendrocyte myelination, particularly in optic nerves during critical developmental windows .
What is the relationship between CC2D1B and the ESCRT-III complex in endosomal trafficking?
CC2D1B appears functionally involved in ESCRT-III-mediated processes, similar to its Drosophila ortholog Lgd. Key experimental findings supporting this relationship include:
-
Protein-protein interactions: Proximity ligation assays (PLA) have demonstrated endogenous interactions between CC2D1A and CHMP4B (an ESCRT-III component) in wild-type MEF cells .
-
Endosomal localization: Both CC2D1A and overexpressed CC2D1B accumulate on enlarged endosomal vesicles in Vps4a+/-, Vps4b+/- cells, indicating association with endosomal membranes .
-
VPS4-dependent cycling: Evidence suggests CC2D1B cycles between the cytosol and endosomal membranes and is removed from endosomal membranes by VPS4, a key regulator of ESCRT-III disassembly .
-
Endosomal morphology defects: Electron microscopy analysis revealed that Cc2d1a mutant cells show increased average endosome size, indicating a defect in endosomal morphogenesis .
-
Functional conservation: In rescue experiments in Drosophila melanogaster, both CC2D1A and CC2D1B were able to functionally replace Lgd, suggesting conservation of ESCRT-III-related functions .
These findings suggest CC2D1B plays a role in ESCRT-III-mediated endosomal trafficking, though the precise molecular mechanisms and physiological significance remain under investigation .
How does CC2D1B function in nuclear envelope reformation during mitosis?
CC2D1B plays a critical role during mitotic reformation of the nuclear envelope, with functional implications for post-mitotic nuclear compartmentalization:
-
Localization during mitosis: GFP-tagged CC2D1B localizes to the reforming nuclear envelope during telophase .
-
Membrane binding requirement: The C2 domain of CC2D1B is essential for this function, as a C2 domain mutant (GFP-CC2D1B-C2M) fails to localize to the reforming nuclear envelope .
-
Functional significance: Wild-type CC2D1B expression rescues nuclear compartmentalization defects (measured by mCherry-NLS nuclear recovery), while the C2 domain mutant fails to provide rescue activity .
-
Nuclear morphology effects: Expression of wild-type CC2D1B, but not the C2 domain mutant, reduces the proportion of cells with aberrant nuclear morphology .
These findings suggest that CC2D1B's membrane-binding capacity through its C2 domain is essential for proper nuclear envelope reformation following mitosis, with direct impacts on nuclear compartmentalization and morphology .
How do CC2D1A and CC2D1B differ functionally despite structural similarity?
Despite belonging to the same protein family, CC2D1A and CC2D1B display several important functional differences:
| Characteristic | CC2D1A | CC2D1B |
|---|---|---|
| Expression pattern | Highly expressed in neurons | Predominantly in myelinating glial cells and peripheral nerves |
| Knockout phenotype | Lethal shortly after birth due to respiratory distress | No obvious general phenotype; specific hypomyelination in optic nerves |
| Known functions | Centrosomal cleavage, signaling pathways (EGFR, cAMP/PKA), immune response, synapse maturation | Developmental myelination, transcriptional repression of 5-HT1A receptor |
| Disease associations | Severe intellectual disability and autism spectrum disorders | Not extensively documented |
| Endosomal phenotype | Cc2d1a mutant cells show increased endosome size | Not directly demonstrated |
While both proteins can functionally replace Lgd in Drosophila rescue experiments, indicating some conserved functions, their distinct expression patterns and knockout phenotypes suggest they have evolved specialized roles in different cell types and biological processes .
What are the optimal conditions for using CC2D1B antibody in Western blotting?
For successful Western blot detection of CC2D1B, researchers should consider these technical parameters:
-
Antibody dilution: Optimal results are typically achieved at dilutions between 1:1000 and 1:4000 .
-
Expected molecular weight: While the calculated molecular weight is approximately 94 kDa, CC2D1B typically appears at around 120 kDa due to post-translational modifications .
-
Validated positive samples: Reliable detection has been demonstrated in mouse brain tissue, human placenta tissue, mouse kidney tissue, and SH-SY5Y cells .
-
Sample preparation: Standard protocols for membrane-associated proteins are generally effective, with particular attention to including protease inhibitors.
-
Controls for specificity:
-
Signal detection: Both chemiluminescence and fluorescence-based detection methods have been successfully employed, with the latter offering better quantification potential.
-
Loading controls: Housekeeping proteins like calnexin have been successfully used as normalization controls in published studies .
How can researchers effectively use CC2D1B antibody for detecting protein-protein interactions?
For investigating CC2D1B protein interactions, several methodological approaches have proven effective:
-
Immunoprecipitation (IP):
-
Proximity Ligation Assay (PLA):
-
Co-localization studies:
-
Cross-linking approaches:
-
May help capture transient interactions
-
Particularly relevant for CC2D1B's dynamic cycling between cytosol and membranes
-
-
Context considerations:
How can researchers troubleshoot non-specific binding when using CC2D1B antibody?
When facing non-specific binding issues with CC2D1B antibody, consider these troubleshooting approaches:
-
Verify antibody specificity:
-
Optimize blocking conditions:
-
Increase blocking reagent concentration (5-10% BSA or normal serum)
-
Use serum from the species in which the secondary antibody was raised
-
Consider alternative blockers for problematic applications
-
-
Antibody titration:
-
Enhance washing stringency:
-
Increase salt concentration in wash buffers
-
Adjust detergent concentration (0.1-0.3% Triton X-100)
-
Extend washing duration and increase wash frequency
-
-
Pre-absorption validation:
-
Pre-incubate antibody with purified CC2D1B protein before application
-
Should dramatically reduce specific signal while leaving non-specific binding unchanged
-
-
Check for degradation products:
-
Application-specific controls:
What are the implications of CC2D1B in neurodevelopmental research?
CC2D1B's role in neurodevelopment presents several important research avenues:
-
Myelination regulation: The hypomyelination phenotype in Cc2d1b knockout optic nerves suggests CC2D1B influences developmental myelination specifically in the central nervous system .
-
Cell-type specific functions: High expression in myelinating glial cells indicates specialized functions distinct from its homolog CC2D1A, which is primarily neuronal .
-
Temporal regulation: The expression peak of Cc2d1b between postnatal days 5-20 coincides with critical periods of myelination, suggesting developmental stage-specific functions .
-
Transcriptional regulation: As a transcriptional repressor, CC2D1B may control expression of genes critical for proper neural development and myelination .
-
Potential disease associations: While CC2D1A mutations are linked to intellectual disability and autism spectrum disorders, the disease relevance of CC2D1B variants remains less explored but potentially significant .
-
Regional specificity: The specific myelination defect in optic nerves rather than throughout the CNS suggests region-specific functions that warrant further investigation .
-
Therapeutic implications: Understanding CC2D1B's role in myelination could inform approaches to demyelinating diseases or developmental disorders affecting white matter.
What emerging techniques might advance CC2D1B research?
Several cutting-edge methodologies could significantly enhance our understanding of CC2D1B function:
-
Single-cell proteomics: Techniques like CITE-seq with appropriate normalization methods could reveal cell type-specific expression patterns and protein interactions of CC2D1B at unprecedented resolution .
-
Proximity labeling methods: BioID or APEX2 fusion proteins could map the CC2D1B interactome in specific subcellular compartments, helping resolve its dynamic associations with endosomal machinery.
-
Super-resolution microscopy: Techniques like STORM or PALM could better visualize CC2D1B's association with endosomal membranes and the reforming nuclear envelope with nanometer precision.
-
Live-cell imaging: Fluorescently tagged CC2D1B combined with lattice light-sheet microscopy could track its dynamic localization during processes like mitosis or endosomal trafficking.
-
Tissue-specific conditional knockouts: Cre-loxP systems targeting myelinating cells could better dissect CC2D1B's role in specific neural cell populations without developmental compensation.
-
CRISPR-based screens: Genome-wide or targeted screens could identify genetic interactions and pathways involving CC2D1B.
-
Protein structure determination: Cryo-EM or X-ray crystallography of CC2D1B, particularly its C2 domain, could provide insights into its membrane-binding mechanisms and potential for targeted modulation.
How might CC2D1B research contribute to understanding neurological disorders?
CC2D1B research holds potential implications for several neurological conditions:
-
Demyelinating disorders: Understanding CC2D1B's role in myelination could provide insights into diseases like multiple sclerosis or leukodystrophies where myelin integrity is compromised .
-
Neurodevelopmental disorders: While CC2D1A mutations are linked to intellectual disability and autism, CC2D1B variants might contribute to related conditions with different presentations or affected brain regions .
-
Visual system pathologies: The specific hypomyelination in optic nerves of Cc2d1b knockout mice suggests potential relevance to visual system disorders involving white matter abnormalities .
-
Endosomal trafficking disorders: CC2D1B's role in ESCRT-III functions connects it to cellular pathways implicated in neurodegeneration and lysosomal storage disorders .
-
Nuclear envelope disorders: Its role in nuclear envelope reformation links CC2D1B to a class of diseases called laminopathies that affect nuclear structure and function .
-
Receptor trafficking disorders: Through its endosomal functions, CC2D1B may influence receptor trafficking relevant to various neuropsychiatric conditions .
Research on CC2D1B could ultimately contribute to biomarker development, understanding disease mechanisms, or identifying novel therapeutic targets for these conditions.
